Antidiabetic Agents for Treatment of Parkinson’s Disease: A Meta-Analysis

Background: Clinical and epidemiological studies suggest that two of the most common geriatric diseases, type 2 diabetes and Parkinson’s disease (PD), are linked. These studies notably suggest that treatment of insulin resistance in type 2 diabetes may beneficially modify the pathophysiology of PD a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shu-Yi, Wu, Shey-Lin, Chen, Ta-Cheng, Chuang, Chieh-Sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369739/
https://www.ncbi.nlm.nih.gov/pubmed/32635358
http://dx.doi.org/10.3390/ijerph17134805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369739/
https://www.ncbi.nlm.nih.gov/pubmed/32635358
http://dx.doi.org/10.3390/ijerph17134805

Ejemplares similares